epigallocatechin gallate has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kay, NE; Kumazoe, M; Lesnick, C; Shanafelt, TD; Tachibana, H; Tsukamoto, S; Yamada, K | 1 |
| Cornwall, S; Cull, G; Ghassemifar, R; Joske, D | 1 |
| Angelo, LS; Kurzrock, R | 1 |
| Ghosh, AK; Kay, NE; Secreto, CR; Shanafelt, TD | 1 |
| Bowen, DA; Call, TG; Erlichman, C; Ghosh, AK; Jelinek, DF; Kabat, BF; Kay, NE; LaPlant, B; Lee, MJ; Roos, M; Secreto, CR; Shanafelt, TD; Yang, CS; Zent, CS | 1 |
| Kay, NE; O'Brien, S | 1 |
| Bone, ND; Jelinek, DF; Kay, NE; Lee, YK; Shanafelt, TD; Strege, AK | 1 |
| Call, TG; Dingli, D; Kay, NE; Lee, YK; Nowakowski, GS; Shanafelt, TD; Zent, CS | 1 |
| Hamblin, T | 1 |
1 review(s) available for epigallocatechin gallate and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
Maintenance therapy for B-chronic lymphocytic leukemia.
Topics: Antibodies, Monoclonal, Murine-Derived; Catechin; Curcumin; Humans; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Rituximab; Thalidomide | 2011 |
1 trial(s) available for epigallocatechin gallate and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.
Topics: Administration, Oral; Adult; Aged; Anticarcinogenic Agents; Catechin; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Staging; Patient Selection; Tea; Treatment Outcome | 2009 |
8 other study(ies) available for epigallocatechin gallate and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
Vardenafil, a clinically available phosphodiesterase inhibitor, potentiates the killing effect of EGCG on CLL cells.
Topics: Catechin; Cell Line, Tumor; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Imidazoles; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Proteins; Phosphodiesterase 5 Inhibitors; Piperazines; Receptors, Laminin; Ribosomal Proteins; Sulfones; Triazines; Vardenafil Dihydrochloride | 2015 |
Green tea polyphenol "epigallocatechin-3-gallate", differentially induces apoptosis in CLL B-and T-Cells but not in healthy B-and T-Cells in a dose dependant manner.
Topics: Apoptosis; B-Lymphocytes; Catechin; Cells, Cultured; Coculture Techniques; Dose-Response Relationship, Drug; Feeder Cells; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, T-Cell; T-Lymphocytes; Tumor Cells, Cultured | 2016 |
Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia.
Topics: Apoptosis; Catechin; Curcuma; Curcumin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Tea | 2009 |
Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Survival; Curcumin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Myeloid Cell Leukemia Sequence 1 Protein; NF-kappa B; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; STAT3 Transcription Factor; Stromal Cells; X-Linked Inhibitor of Apoptosis Protein | 2009 |
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Catechin; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Phosphorylation; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2004 |
Component in green tea helps kill leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; Catechin; Drug Screening Assays, Antitumor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Tea | 2004 |
Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies.
Topics: Anticarcinogenic Agents; Camellia sinensis; Catechin; Clinical Trials as Topic; Disease-Free Survival; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neoplasm Regression, Spontaneous; Neoplasm Staging; Phytotherapy; Plant Extracts; Radiography; Remission Induction; Tea | 2006 |
Natural products and the treatment of leukemia.
Topics: Anticarcinogenic Agents; Camellia sinensis; Catechin; Clinical Trials as Topic; Disease-Free Survival; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neoplasm Regression, Spontaneous; Neoplasm Staging; Phytotherapy; Plant Extracts; Radiography; Remission Induction; Tea | 2006 |